I spoke to health journalist Julia Belluz, who has reported on Ozempic and is writing a book on obesity, about how semaglutide is changing the way we understand weight loss
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ -- 63%, compared with 34% of those taking a placebo, researchers reported April 30 in the New England Journal of Medicine
Newman says shes seen people use GLP-1s as an appetite suppressant to fuel a restrictive eating disorder
Increasing the dosage and titration is standard, but you dont want to be 12 weeks in, a bit lighter and feeling confident again, about to go from 1 mg per week to 1.7 mg per week, when BOOM
This guide is for the day before your shot, the day of your shot, and the day after your GLP-1 injection
Inventory Management Effective inventory management is a key component of laboratory quality assurance